Integrin expression and adhesivity to fibronectin in primary acute myeloid leukemia cells: Impact of NPM1 and FLT3 mutations.

European Journal of Haematology
Kateřina KuželováZdenka Gašová

Abstract

Interaction of leukemia cells with the bone marrow extracellular matrix promotes cell survival and resistance to chemotherapy. In this work, we analyzed integrin expression and adhesivity to fibronectin in primary cells from patients with acute myeloid leukemia. Surface expression of integrins β1 and αVβ3 on primary leukemia cells (N = 46) was correlated with the stem cell marker CD34, as well as with cell adhesivity to fibronectin. The results were analyzed with regard to the mutational status of NPM1 and FLT3 genes. The integrin β1 was omnipresent, whereas αVβ3 was often more expressed on CD34-positive cells. In particular, higher αVβ3 expression on CD34+ cells was associated with NPM1 mutation (P = .0018). Monocytic leukemias had significantly higher αVβ3 expression compared to less maturated cases (P = .0008). Cells from patients with internal tandem duplications in FLT3 (FLT3-ITD) had lower adhesivity to fibronectin compared to cells with wild-type FLT3 (P = .031), specifically in less differentiated myeloblasts. Inhibition of a putative FLT3-ITD target, EZH2, increased cell adhesivity in MV4-11 cell line (P = .024). The integrin αVβ3 is expressed in particular on CD34+ cells with NPM1 mutation and might have a prognostic ...Continue Reading

References

Apr 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roland B WalterSoheil Meshinchi
Dec 1, 2010·European Journal of Haematology·Akira KatsumiTomoki Naoe
Dec 3, 2014·Cell Reports·Anindya ChatterjeeReuben Kapur
Jan 28, 2017·Nature Communications·Mitasha BharadwajDaniel J Müller
Jan 19, 2018·International Journal of Molecular Sciences·Silje JohansenØystein Bruserud
Dec 14, 2018·Leukemia·Wendelien ZeijlemakerGerrit J Schuurhuis
Jan 20, 2019·Cells·Alicja M GruszkaMyriam Alcalay
Mar 8, 2019·Cancers·Roland WindischChristian Wichmann
Mar 21, 2019·The Journal of Experimental Medicine·Faisal BasheerBrian J P Huntly
Jun 12, 2019·Nature Reviews. Molecular Cell Biology·Jenny Z KechagiaPere Roca-Cusachs
Jun 13, 2019·International Journal of Molecular Sciences·Barbora BrodskáKateřina Kuželová
Jul 25, 2019·Advances in Medical Sciences·Amal MechaalInes Safra

❮ Previous
Next ❯

Citations

Jan 20, 2021·Cell Adhesion & Migration·Kateřina KuželováAleš Holoubek
Jan 12, 2021·Frontiers in Oncology·Hye Na KimYong-Mi Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.